{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:47:18Z","timestamp":1791247638012,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.imlet.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T17:57:27Z","timestamp":1436032647000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mesenchymal stromal cells and rheumatic disorders"],"prefix":"10.1016","volume":"168","author":[{"given":"Alan","family":"Tyndall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2015.05.017_bib0265","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0275","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2015.05.017_bib0280","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","author":"Le Blanc","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrrheum.2013.166","article-title":"Mesenchymal stem cell treatments in rheumatology: a glass half full","volume":"10","author":"Tyndall","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0290","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1634\/stemcells.2007-0528","article-title":"Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients","volume":"26","author":"Traggiai","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.imlet.2015.05.017_bib0295","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/bmt.2009.63","article-title":"Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks","volume":"43","author":"Tyndall","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imlet.2015.05.017_bib0300","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7150\/ijbs.10725","article-title":"Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases","volume":"11","author":"Huang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.imlet.2015.05.017_bib0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fncel.2014.00377","article-title":"Exosomes\/miRNAs as mediating cell-based therapy of stroke","volume":"8","author":"Xin","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.imlet.2015.05.017_bib0310","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4252\/wjsc.v6.i5.644","article-title":"Potential advantages of acute kidney injury management by mesenchymal stem cells","volume":"6","author":"Bianchi","year":"2014","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.imlet.2015.05.017_bib0315","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.imlet.2015.05.017_bib0320","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/annrheumdis-2013-204235","article-title":"FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells","volume":"74","author":"Bocelli-Tyndall","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2015.05.017_bib0325","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0330","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21012","article-title":"Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis","volume":"52","author":"Djouad","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2015.05.017_bib0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/505139a","article-title":"Leaked files slam stem-cell therapy","volume":"505","author":"Abbott","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2015.05.017_bib0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0961203309348983","article-title":"Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients","volume":"19","author":"Carrion","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2015.05.017_bib0345","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/ard.2009.123463","article-title":"Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study","volume":"69","author":"Liang","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2015.05.017_bib0350","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2015.05.017_bib0355","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-012-1943-2","article-title":"Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus","volume":"31","author":"Shi","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0360","article-title":"Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus","author":"Li","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imlet.2015.05.017_bib0365","doi-asserted-by":"crossref","DOI":"10.3727\/096368912X658719","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years experience","author":"Wang","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.imlet.2015.05.017_bib0370","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2012\/273291","article-title":"Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0375","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2015.05.017_bib0380","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","article-title":"Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy","volume":"33","author":"Gu","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0385","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1191\/0961203304lu1067sr","article-title":"Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus","volume":"13","author":"Tam","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2015.05.017_bib0390","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","article-title":"Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L","volume":"22","author":"Christopeit","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.imlet.2015.05.017_bib0395","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/art.30431","article-title":"Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases","volume":"63","author":"Keyszer","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2015.05.017_bib0400","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3727\/096368912X639017","article-title":"Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis","volume":"22","author":"Scuderi","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.imlet.2015.05.017_bib0405","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial","author":"Granel","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2015.05.017_bib0410","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","article-title":"Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis","volume":"48","author":"Nevskaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2015.05.017_bib0415","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","article-title":"Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report","volume":"153","author":"Guiducci","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imlet.2015.05.017_bib0420","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2015.05.017_bib0425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/rheumatology\/keu417","article-title":"Biologic treatment in Sjogren's syndrome","volume":"54","author":"Sada","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2015.05.017_bib0430","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","article-title":"Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis","volume":"70","author":"Wang","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2015.05.017_bib0435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1479-5876-9-181","article-title":"Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells","volume":"9","author":"Ra","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imlet.2015.05.017_bib0440","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","article-title":"Allogeneic mesenchymal stem cells transplantation in patients with refractory RA","volume":"31","author":"Liang","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2015.05.017_bib0445","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1089\/scd.2013.0023","article-title":"Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy","volume":"22","author":"Wang","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.imlet.2015.05.017_bib0450","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3727\/096368913X667727","article-title":"Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial","volume":"23","author":"Wang","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.imlet.2015.05.017_bib0455","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199410063311401","article-title":"Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation","volume":"331","author":"Brittberg","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2015.05.017_bib0460","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00167-012-2329-3","article-title":"Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics","volume":"8","author":"Filardo","year":"2013","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"10.1016\/j.imlet.2015.05.017_bib0465","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13075-014-0432-1","article-title":"Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review","volume":"16","author":"Bornes","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2015.05.017_bib0470","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.arthro.2013.09.074","article-title":"Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years\u2019 follow-up","volume":"29","author":"Wong","year":"2013","journal-title":"Arthroscopy"},{"key":"10.1016\/j.imlet.2015.05.017_bib0475","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0363546509359067","article-title":"Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study","volume":"38","author":"Nejadnik","year":"2010","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.imlet.2015.05.017_bib0480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/joca.2001.0504","article-title":"Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees","volume":"10","author":"Wakitani","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.imlet.2015.05.017_bib0485","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","article-title":"Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis","volume":"19","author":"Koh","year":"2012","journal-title":"Knee"},{"key":"10.1016\/j.imlet.2015.05.017_bib0490","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.arthro.2012.12.008","article-title":"Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial","volume":"29","author":"Saw","year":"2013","journal-title":"Arthroscopy"},{"key":"10.1016\/j.imlet.2015.05.017_bib0495","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00264-015-2685-y","article-title":"Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation","volume":"5","author":"Buda","year":"2015","journal-title":"Int. Orthop."},{"key":"10.1016\/j.imlet.2015.05.017_bib0500","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2015.05.017_bib0505","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2015.05.017_bib0510","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2015.05.017_bib0515","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2015.05.017_bib0520","series-title":"Abstract at the Annual Scientific Meeting ACR","author":"Alvaro-Gracia","year":"2013"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:16:30Z","timestamp":1566951390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0165247815000930"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.05.017","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells and rheumatic disorders","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}